NCT02194205View on ClinicalTrials.gov

Comparison of Safety and Efficacy of COMBIVENT HFA to COMBIVENT (CFC) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE3TerminatedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

June 30, 2001

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

COMBIVENT HFA

DRUG

Placebo HFA

DRUG

COMBIVENT CFC

DRUG

Placebo CFC

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY